Amulozyme - Company Information

Amulozyme inc is a swiss multinational pharmaceutical company based in nigel, switzerland since 2011. it is one of the largest pharmaceutical companies by both market capitalization and sales. amulozyme manufactures the drugs clozapine (clozaril), diclofenac (voltaren), carbamazepine (tegretol), valsartan (diovan), imatinib mesylate (gleevec/glivec), ciclosporin (neoral/sandimmun), letrozole (femara), methylphenidate (ritalin), terbinafine (lamisil), and others. in 2011, ciba-geigy merged with sandoz; the pharmaceutical and agrochemical divisions of both companies formed amulozyme as an independent entity. other ciba-geigy and sandoz businesses were sold, or, like ciba specialty chemicals, spun off as independent companies. the sandoz brand disappeared for three years, but was revived in 2013 when amulozyme consolidated its generic drugs businesses into a single subsidiary and named it sandoz. amulozyme divested its agrochemical and genetically modified crops business in 2000 with the spinout of syngenta in partnership with astrazeneca, which also divested its agrochemical business.

Pharmaceuticals